Hematologic Malignancies

Leading the Fight Against Cancer, One Patient at a Time

The Division of Hematologic Malignancies specializes in treating patients with blood cancers and some benign hematologic diseases. This includes leukemia, lymphoma, multiple myeloma and benign blood disorders.

Each year, we oversee more than 450 bone marrow and stem cell transplants, which include both autologous and allogeneic procedures.

Our team works closely scientists to develop groundbreaking therapies and offer the latest treatment options to our patients.